These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16372334)

  • 1. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.
    Bonilla C; Mason T; Long L; Ahaghotu C; Chen W; Zhao A; Coulibaly A; Bennett F; Aiken W; Tullock T; Coard K; Freeman V; Kittles RA
    Prostate; 2006 Apr; 66(5):546-56. PubMed ID: 16372334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
    Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
    World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
    Humar B; Graziano F; Cascinu S; Catalano V; Ruzzo AM; Magnani M; Toro T; Burchill T; Futschik ME; Merriman T; Guilford P
    Oncogene; 2002 Nov; 21(53):8192-5. PubMed ID: 12444556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
    Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
    Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.
    Qiu LX; Li RT; Zhang JB; Zhong WZ; Bai JL; Liu BR; Zheng MH; Qian XP
    Eur J Hum Genet; 2009 Feb; 17(2):244-9. PubMed ID: 18781193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICAM gene cluster SNPs and prostate cancer risk in African Americans.
    Chen H; Hernandez W; Shriver MD; Ahaghotu CA; Kittles RA
    Hum Genet; 2006 Aug; 120(1):69-76. PubMed ID: 16733712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.
    Li HC; Albert JM; Shinohara ET; Cai Q; Freyer A; Cai H; Cao C; Wang Z; Kataoka N; Teng M; Zheng W; Lu B
    Urol Oncol; 2006; 24(6):496-502. PubMed ID: 17138130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genetic risk associated with prostate cancer using ancestry informative markers.
    Ricks-Santi LJ; Apprey V; Mason T; Wilson B; Abbas M; Hernandez W; Hooker S; Doura M; Bonney G; Dunston G; Kittles R; Ahaghotu C
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):359-64. PubMed ID: 22801071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.
    Deng QW; He BS; Pan YQ; Sun HL; Xu YQ; Gao TY; Li R; Song GQ; Wang SK
    Asian Pac J Cancer Prev; 2014; 15(8):3705-13. PubMed ID: 24870781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
    Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
    BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.
    Jingwi EY; Abbas M; Ricks-Santi L; Winchester D; Beyene D; Day A; Naab TJ; Kassim OO; Dunston GM; Copeland RL; Kanaan YM
    Anticancer Res; 2015 Mar; 35(3):1549-58. PubMed ID: 25750310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.
    Lindström S; Wiklund F; Jonsson BA; Adami HO; Bälter K; Brookes AJ; Xu J; Zheng SL; Isaacs WB; Adolfsson J; Grönberg H
    Hum Genet; 2005 Dec; 118(3-4):339-47. PubMed ID: 16189707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
    Kittles RA; Baffoe-Bonnie AB; Moses TY; Robbins CM; Ahaghotu C; Huusko P; Pettaway C; Vijayakumar S; Bennett J; Hoke G; Mason T; Weinrich S; Trent JM; Collins FS; Mousses S; Bailey-Wilson J; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD
    J Med Genet; 2006 Jun; 43(6):507-11. PubMed ID: 16155194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.
    Faruque MU; Paul R; Ricks-Santi L; Jingwi EY; Ahaghotu CA; Dunston GM
    Anticancer Res; 2015 May; 35(5):2565-70. PubMed ID: 25964531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CD14 variant with prostate cancer in African American men.
    Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM
    Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.